Transcript
A (0:00)
Showing that the end to end system for de extinction and species preservation works with what we've been able to achieve with our direwolves, as well as the work that we were able to do our trait engineering with our, with our woolly mice.
B (0:12)
So why do you want to bring back the woolly mammoth?
A (0:14)
There's not a better, like, cultural animal icon than the mammoth, right? It's almost like it's. It almost feels like a dinosaur. People think that it like went extinct 65 million years ago, but it's just, just out of like human memory. Most people don't know this, but we were actually building the pyramids while mammoths still existed on this earth. And so the idea that we could like, bring back this icon and have this massive, like, feat of science and inspire the next generation while also building technologies to help elephants is something that's pretty exciting, right? I don't know if there's a cooler.
B (0:51)
Science project on the planet before this podcast. I congratulate you on the last round, which was value the company at 10.3 billion. And you said, we're just getting started. What did you mean by that?
A (1:03)
We've shown that the end to end system for de extinction and species preservation works with what we've been able to achieve with our dire wolves, as well as the work that we were able to do our trait engineering with our woolly mice. And so if you look at how we scale genome engineering over the Next, you know, two to 10 years, I think we're going to completely change what's possible in terms of synthetic biology. And so I think a lot of species that have gone extinct, you know, aren't just going to be on the verge of bringing back. I think we're going to see them back on this planet. And so I think over time we'll have a whole kind of portfolio of animals that we've been able to bring back and hopefully successfully reintroduce in the ecosystem. So I think that that colossal. While people are excited in taking victory labs on the technology achievements and some of the financial achievements, we haven't even really started compared to where we think we're going.
B (1:53)
Tell me about the business model today and what you plan for the future.
A (1:57)
If you create a lot of value and you, you build a lot of technologies and you solve hard problems, you always find ways to monetize. So the original business model was, hey, if we go do this, there's probably something valuable along the way. We're now figuring that out. Right. The midterm goal, which we're in right now is spinning bidding out technology companies, right? And so as we develop these different technologies and as we develop this pipeline for de extinction, we're having to innovate across everything from like genome engineering to computational biology, to cellular engineering, to even cloning. And so all of those different technologies have different applications to human healthcare, to animal, to plants, all over the board. So we've successfully spun out three companies, two of which we've announced, right. The third one we haven't announced, which we're pretty excited about. And they've in. Our first two companies are valued over $100 million, right. So I think we're starting to show that the value in not just the technology that we're developing, but as they can be packaged into a specific use case, a specific target company is pretty interesting. And I think over time, you know, we'll build more and more companies. Long term, what we're finding is that governments are now coming back, coming to us for everything from biobanking to genetic rescue and help saving species as well as like, what are the long term applications to rewilding the extinct species back? Everything from carbon credits to ecotourism. So we're really looking at both the technologies and the animals as ways to monetize both short, mid and long term.
